Skip to main content

Peer Review reports

From: Phase II study of olaparib in patients with refractory Ewing sarcoma following failure of standard chemotherapy

Original Submission
29 Jun 2014 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
6 Aug 2014 Reviewed Reviewer Report - Mohamad Farid
14 Aug 2014 Reviewed Reviewer Report - Richard Quek
19 Sep 2014 Author responded Author comments - Edwin Choy
Resubmission - Version 3
19 Sep 2014 Submitted Manuscript version 3
1 Oct 2014 Author responded Author comments - Edwin Choy
Resubmission - Version 4
1 Oct 2014 Submitted Manuscript version 4
Publishing
2 Oct 2014 Editorially accepted
5 Nov 2014 Article published 10.1186/1471-2407-14-813

You can find further information about peer review here.

Back to article page